These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 32332711)

  • 1. Intervention of oncostatin M-driven mucosal inflammation by berberine exerts therapeutic property in chronic ulcerative colitis.
    Li H; Feng C; Fan C; Yang Y; Yang X; Lu H; Lu Q; Zhu F; Xiang C; Zhang Z; He P; Zuo J; Tang W
    Cell Death Dis; 2020 Apr; 11(4):271. PubMed ID: 32332711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective role of berberine on ulcerative colitis through modulating enteric glial cells-intestinal epithelial cells-immune cells interactions.
    Li H; Fan C; Lu H; Feng C; He P; Yang X; Xiang C; Zuo J; Tang W
    Acta Pharm Sin B; 2020 Mar; 10(3):447-461. PubMed ID: 32140391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feiyangchangweiyan capsule protects against ulcerative colitis in mice by modulating the OSM/OSMR pathway and improving gut microbiota.
    Li Y; Chen F; Xie Y; Yang Q; Luo H; Jia P; Shi Z; Wang S; Zheng X
    Phytomedicine; 2021 Jan; 80():153372. PubMed ID: 33113505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Berberine ameliorates DSS-induced intestinal mucosal barrier dysfunction through microbiota-dependence and Wnt/β-catenin pathway.
    Dong Y; Fan H; Zhang Z; Jiang F; Li M; Zhou H; Guo W; Zhang Z; Kang Z; Gui Y; Shou Z; Li J; Zhu R; Fu Y; Sarapultsev A; Wang H; Luo S; Zhang G; Hu D
    Int J Biol Sci; 2022; 18(4):1381-1397. PubMed ID: 35280677
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Li Y; Yang X; Yuan JN; Lin R; Tian YY; Li YX; Zhang Y; Wang XF; Xie YH; Wang SW; Zheng XH
    Front Pharmacol; 2022; 13():819826. PubMed ID: 35645824
    [No Abstract]   [Full Text] [Related]  

  • 6. [Research progress of effect of berberine in treatment of ulcerative colitis based on cell signaling pathway].
    Wang JJ; Wang J; Li Y; Ren MH; Fu Y; Yang XJ; Wang LY
    Zhongguo Zhong Yao Za Zhi; 2021 Jan; 46(1):33-40. PubMed ID: 33645048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of phosphodiesterase-4 attenuates murine ulcerative colitis through interference with mucosal immunity.
    Li H; Fan C; Feng C; Wu Y; Lu H; He P; Yang X; Zhu F; Qi Q; Gao Y; Zuo J; Tang W
    Br J Pharmacol; 2019 Jul; 176(13):2209-2226. PubMed ID: 30883697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Berberine ameliorates chronic relapsing dextran sulfate sodium-induced colitis in C57BL/6 mice by suppressing Th17 responses.
    Li YH; Xiao HT; Hu DD; Fatima S; Lin CY; Mu HX; Lee NP; Bian ZX
    Pharmacol Res; 2016 Aug; 110():227-239. PubMed ID: 26969793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. iTRAQ-based pharmacoproteomics reveals potential targets of berberine, a promising therapy for ulcerative colitis.
    Li YH; Sun W; Zhou BJ; Rosenstein A; Zhao J; Wang J; Bian ZX
    Eur J Pharmacol; 2019 May; 850():167-179. PubMed ID: 30771347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Berberine in the treatment of ulcerative colitis: A possible pathway through Tuft cells.
    Xiong X; Cheng Z; Wu F; Hu M; Liu Z; Dong R; Chen G
    Biomed Pharmacother; 2021 Feb; 134():111129. PubMed ID: 33348308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxyberberine, a novel gut microbiota-mediated metabolite of berberine, possesses superior anti-colitis effect: Impact on intestinal epithelial barrier, gut microbiota profile and TLR4-MyD88-NF-κB pathway.
    Li C; Ai G; Wang Y; Lu Q; Luo C; Tan L; Lin G; Liu Y; Li Y; Zeng H; Chen J; Lin Z; Xian Y; Huang X; Xie J; Su Z
    Pharmacol Res; 2020 Feb; 152():104603. PubMed ID: 31863867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addition of Berberine to 5-Aminosalicylic Acid for Treatment of Dextran Sulfate Sodium-Induced Chronic Colitis in C57BL/6 Mice.
    Li YH; Zhang M; Xiao HT; Fu HB; Ho A; Lin CY; Huang Y; Lin G; Bian ZX
    PLoS One; 2015; 10(12):e0144101. PubMed ID: 26642326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Berberine ameliorates colonic damage accompanied with the modulation of dysfunctional bacteria and functions in ulcerative colitis rats.
    Liao Z; Xie Y; Zhou B; Zou B; Xiao D; Liu W; Cai Y; Liu D; Liao Q; Xie Z
    Appl Microbiol Biotechnol; 2020 Feb; 104(4):1737-1749. PubMed ID: 31867696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Berberine Suppresses Colonic Inflammation in Dextran Sulfate Sodium-Induced Murine Colitis Through Inhibition of Cytosolic Phospholipase A2 Activity.
    Zhai L; Huang T; Xiao HT; Wu PG; Lin CY; Ning ZW; Zhao L; Kwan HYA; Hu XJ; Wong HLX; Li XQ; Bian ZX
    Front Pharmacol; 2020; 11():576496. PubMed ID: 33658925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effects of berberine hydrochloride on DSS-induced ulcerative colitis in rats.
    Zhu L; Gu P; Shen H
    Int Immunopharmacol; 2019 Mar; 68():242-251. PubMed ID: 30743078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gegen Qinlian decoction maintains colonic mucosal homeostasis in acute/chronic ulcerative colitis via bidirectionally modulating dysregulated Notch signaling.
    Zhao Y; Luan H; Gao H; Wu X; Zhang Y; Li R
    Phytomedicine; 2020 Mar; 68():153182. PubMed ID: 32065953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artesunate ameliorates DSS-induced ulcerative colitis by protecting intestinal barrier and inhibiting inflammatory response.
    Yin S; Yang H; Tao Y; Wei S; Li L; Liu M; Li J
    Inflammation; 2020 Apr; 43(2):765-776. PubMed ID: 31897917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-inflammatory Efficacy of Combined Natural Alkaloid Berberine and S1PR Modulator Fingolimod at Low Doses in Ulcerative Colitis Preclinical Models.
    Han Q; Tang HZ; Zou M; Zhao J; Wang L; Bian ZX; Li YH
    J Nat Prod; 2020 Jun; 83(6):1939-1949. PubMed ID: 32432470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of total triterpenoids of Chaenomeles speciosa on PPARγ/SIRT1/NF-κBp65 signaling pathway and intestinal mucosal barrier of ulcerative colitis induced by DSS in mice].
    Xiong XJ; Li XM; He YM; Li XQ; Xu HY; Feng ML; He HB; Zhang JH; Zhu S; Komatsu Katsuko ; Zou K
    Zhongguo Zhong Yao Za Zhi; 2018 Nov; 43(21):4295-4304. PubMed ID: 30583632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced therapeutic efficacy of a novel colon-specific nanosystem loading emodin on DSS-induced experimental colitis.
    Wang D; Sun M; Zhang Y; Chen Z; Zang S; Li G; Li G; Clark AR; Huang J; Si L
    Phytomedicine; 2020 Nov; 78():153293. PubMed ID: 32777486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.